Dublin, Ireland, and Cheshire, UK, 04 September 2024: ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, and Medicines Discovery Catapult (‘MDC’), an independent, not-for-profit drug discovery innovation center, have signed a non-exclusive commercial-use CRISPR license agreement.
Pharmalittle: We’re reading about a CEO change at AbbVie, a long-acting HIV drug, and more
Rise and shine, everyone. The middle of the week is upon us. Have heart, though. You made it this far, so why not hang on